Gregory W. Ruhnke to Radiopharmaceuticals
This is a "connection" page, showing publications Gregory W. Ruhnke has written about Radiopharmaceuticals.
Connection Strength
0.064
-
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2017 Aug 01; 35(22):2580-2587.
Score: 0.064